jueves, 23 de octubre de 2008

MERCK navega GARDASIL por aguas prohibidas...?

Oct.17 (Bloomberg) Merck&Co is targeting its cervical cancer vaccine Gardasil to women who may not benefit from it after U.S. sales shrank in July and August.

The number of Gardasil vaccinations tumbled more than 33 percent in those two months from the year-earlier period, according to health research firm IMS Health Inc. Merck shifted its marketing to women ages 19 to 26, who have been less likely to get the shots.


No hay comentarios: